Videos

How I Practice Now: Innovative Ways for Treating Autoimmune Patients During a Crisis

07/14/2020

In this video, Vikas Majithia, MD, talks about how the COVID-19 pandemic has affected the treatment of autoimmune patients at his practice in Mississippi. Read the transcript here.

Vikas Majithia, MD, is professor of medicine, chief of the Division of Rheumatology, and fellowship program director at the University of Mississippi Medical Center in Jackson, Mississippi.

Stay in the Know

Rheumatology & Arthritis Newsletter

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1

Popular Articles

Q&As

Nicole Bitencourt, MD, on the Transition From Pediatric to Adult Care

10/21/2020

Successfully transferring a patient with a rheumatic condition from pediatric care to adult care can be challenging. Although there are obstacles to a smooth transition, findings from a recent study are now...

...

10/21/2020

Rheumatology & Arthritis

Quiz

Pop Quiz: Treatment of Ankylosing Spondylitis

07/14/2020

According to the 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis...

...

07/14/2020

Rheumatology & Arthritis

Videos

How I Practice Now: Telemedicine and Financial Challenges of the Pandemic

05/15/2020

In this video, Neal Birnbaum, MD, from Pacific Rheumatology Associates, talks about the challenges he has faced during the COVID-19 pandemic, including those associated with telemedicine and the financial burden.

In this video, Neal Birnbaum,...

05/15/2020

Rheumatology & Arthritis

Quiz

Pop Quiz: Infantile Systemic Hyalinosis

03/11/2020

Infantile systemic hyalinosis (ISH) is a progressive disease that typically results in death by what age?Infantile systemic hyalinosis (ISH) is a progressive disease that typically results in death by what...

...

03/11/2020

Rheumatology & Arthritis

MEASURE 3 Study Results Show Biologic’s Long-Term Safety, Efficacy in AS

01/24/2020

Secukinumab, 150 mg, is a safe and effective long-term treatment option for patients with active ankylosing spondylitis (AS), according to results of the phase 3 MEASURE 3 study.  Although participants who...

...

01/24/2020

Rheumatology & Arthritis

How I Practice Now: Innovative Ways for Treating Autoimmune Patients During a Crisis

Stay in the Know

Partner Spotlight

Popular Articles

Specialties

Events

Year Round Education

HMP Global Products